These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6148709)

  • 1. Interpretation of changes in apomorphine-induced stereotyped behaviour in rats receiving continuous administration of trifluorperazine for 15 months.
    Rupniak NM; Boyce S; Jenner P; Marsden CD
    Neuropharmacology; 1984 Aug; 23(8):893-8. PubMed ID: 6148709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of discontinuous drug administration on the development of dopamine receptor supersensitivity during chronic trifluoperazine or cis-flupenthixol administration to rats.
    Murugaiah K; Theodorou A; Clow A; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1985; 86(1-2):228-32. PubMed ID: 3927361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in dopamine-mediated behaviour during one year's neuroleptic administration.
    Clow A; Jenner P; Marsden CD
    Eur J Pharmacol; 1979 Aug; 57(4):365-75. PubMed ID: 39769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration.
    Clow A; Theodorou A; Jenner P; Marsden CD
    Eur J Pharmacol; 1980 May; 63(2-3):145-57. PubMed ID: 6103814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of apomorphine-induced stereotyped behaviour by acute treatment with dopamine depleting agents: a potential role for an increased stimulation of D1 dopamine receptors.
    Vasse M; Protais P
    Neuropharmacology; 1989 Sep; 28(9):931-9. PubMed ID: 2554186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced stereotyped response to apomorphine after chronic D-1 blockade with SCH 23390.
    Vaccheri A; Dall'Olio R; Gandolfi O; Roncada P; Montanaro N
    Psychopharmacology (Berl); 1987; 91(3):394-6. PubMed ID: 2882541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of yohimbine and neuroleptics on apomorphine-induced pecking behaviour in the pigeon.
    Akbas O; Verimer T; Onur R; Kayaalp SO
    Neuropharmacology; 1984 Nov; 23(11):1261-4. PubMed ID: 6152018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual and morphological differences in the behavioural response to apomorphine in rats.
    Havemann U; Magnus B; Möller HG; Kuschinsky K
    Psychopharmacology (Berl); 1986; 90(1):40-8. PubMed ID: 3094060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of stereotypy induced by nomifensine in rats during continuous chronic haloperidol treatment.
    Rupniak NM; Jenner P; Marsden CD
    Neurosci Lett; 1984 Sep; 50(1-3):63-5. PubMed ID: 6541767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous activity and apomorphine stereotypy during and after withdrawal from 3 1/2 months continuous administration of haloperidol: some methodological issues.
    Waddington JL; Gamble SJ
    Psychopharmacology (Berl); 1980; 71(1):75-7. PubMed ID: 6779327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of some atypical neuroleptics on apomorphine-induced behaviors as a measure of their relative potencies in blocking presynaptic versus postsynaptic dopamine receptors.
    Robertson A; MacDonald C
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1639-43. PubMed ID: 2874567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motility and stereotyped behaviour induced by amphetamine and apomorphine on hypophysectomized and on thyroidectomized rats.
    Benakis A
    Arch Toxicol Suppl; 1979; (2):105-9. PubMed ID: 288325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of scopolamine pretreatment on stereotyped behavior induced by apomorphine in rats withdrawn from long-term haloperidol administration.
    De-Souza H; Palermo-Neto J
    Braz J Med Biol Res; 1981 Oct; 14(4-5):281-4. PubMed ID: 7201335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injection of apomorphine--a test to predict individual different dopaminergic sensitivity?
    Surmann A; Havemann-Reinecke U
    J Neural Transm Suppl; 1995; 45():143-55. PubMed ID: 8748620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some central effects of opioid antagonists. Part I.
    Skorupska M; Langwiński R
    Pol J Pharmacol Pharm; 1989; 41(5):401-11. PubMed ID: 2577060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of apomorphine administration on rearing activity of control and experimental rats withdrawn from long-term haloperidol treatment.
    Bernardi MM; Palermo-Neto J
    Gen Pharmacol; 1984; 15(4):363-5. PubMed ID: 6541605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of striatal and mesolimbic dopamine function in the rat during 6-month trifluoperazine administration.
    Clow A; Theodorou A; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1980; 69(3):227-33. PubMed ID: 6774362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the acute actions of amine-depleting drugs and dopamine receptor antagonists on dopamine function in the brain in rats.
    Hong M; Jenner P; Marsden CD
    Neuropharmacology; 1987; 26(2-3):237-45. PubMed ID: 2884588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of the dopamine antagonist remoxipride on apomorphine induced behaviour in the rat.
    Ståhle L; Ljungberg T; Rodebjer A; Ogren SO; Ungerstedt U
    Pharmacol Toxicol; 1987 Mar; 60(3):227-32. PubMed ID: 2884654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of d,l-propranolol on apomorphine induced stereotyped behavior in rats.
    Poli A; Palermo-Neto J
    Gen Pharmacol; 1987; 18(2):149-52. PubMed ID: 3569842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.